- Report
- October 2022
- 227 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- December 2023
- 319 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Report
- August 2023
- 66 Pages
Global
€7281EUR$8,000USD£6,184GBP
- Report
- September 2024
- 90 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 109 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2022
- 95 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- July 2021
- 277 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- November 2019
- 440 Pages
- Book
- November 2019
- 368 Pages
- Book
- November 2017
- 628 Pages
Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more